RRM1 and lung cancer: The retrospective biomarker sub-study of another randomized phase III trial did not find a prognostic impact of RRM1 protein expression in a subgroup of lung cancer patients randomly assigned to cisplatin-based chemotherapy including gemcitabine [13].